

(Alliance News) - The following is a round-up of updates by London-listed companies, issued this week and not separately reported by Alliance News:


LONDON BROKER RATINGS: Jefferies cuts Berkeley, Barratt and Bellway


Study shows potential for Angle's Parsortix system in clinical trials


Angle says Parsortix system could replace cancer tissue biopsy


Angle cancer study delayed as accreditation process for labs starts


TRADING UPDATES: Harvest Minerals sales jump; Quartix earnings to rise


EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair


Angle first-half loss widens, crucial FDA decision expected this year